ArticlePharmacoepidemiology and drug safety2014

Is sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study.

Alex Dregan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.